Image Credit: ACROBiosystems
Brain disorders are a leading cause of disability and the second-highest source of mortality in the world.1 The impact of brain disorders on economic and social outcomes surpasses that of cardiovascular disease as well as cancer, with their global burden projected to double by 2050.2
Due to the significant impact of brain disorders on global health, the diagnosis and intervention of major brain-related diseases are at the forefront of research into the brain.3 This includes efforts to improve the management of neurological conditions like Parkinson’s disease and neuropsychiatric conditions such as depression.3,4
In addition, ACROBiosystems, a leading manufacturer of cutting-edge tools, reagents, and equipment for biological drug development, have developed Aneuro.3
Aneuro: An Overview of Neuroscience Research
Aneuro provides an extensive selection of high-quality protein tools for in vitro diagnostic research targeting neurological conditions. Its goal is to equip researchers with resources and innovative insights to expedite the development of new diagnostics and treatments.
The range of products Aneuro offers caters to a wide spectrum of brain-related disorders, such as neurodegenerative disorders (including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and Huntington’s disease), functional neurological disorders (like epilepsy and neuropathic pain), neuropsychiatric conditions (depression, autism spectrum disorder), neuroinflammatory diseases (encephalitis, meningitis), neurovascular conditions (stroke, subarachnoid hemorrhage), and structural brain diseases (brain tumors and spinal muscular atrophy). These instruments are vital for pioneering research in neuroscience and advancing global health initiatives.
The Aneuro: Year in Review eBook from ACROBisosytems presents a comprehensive overview of current research innovations, articles, and interviews in the neurology and neuroscience spaces.
References and further reading
1. World Federation of Neurology. (2023). Number of People Living With Brain Disease Expected to Double by 2050. [Online] World Federation of Neurology. Available at: https://wfneurology.org/activities/news-events/neurology-news/2023-10-16-wcn (Accessed on 7 January 2020).
2. Davenport, L. (2023). Global Burden of Brain Disorders Surpasses CVD, Cancer. [Online] Mescape. Available at: https://www.medscape.com/viewarticle/994287?form=fpf (Accessed on 7 January 2020).
3. ACROBiosystems. (no date). Proteins for Neuroscience. [Online] ACROBiosystems. Available at: https://acrobiosystems.com.cn/A1536-Proteins-for-Neuroscience.html (Accessed on 7 January 2020).
4. Perez, AN,. Suarez, J., Le Bars, M., (2023). Sizing the Brain. [Online] Deloitte Insights. Available at: https://www2.deloitte.com/uk/en/insights/industry/health-care/global-neuroscience-market-investment-report.html (Accessed on 7 January 2020).